PHAR
Pharming Group NV
NASDAQ: PHAR · HEALTHCARE · BIOTECHNOLOGY
$16.36
-0.40% today
Updated 2026-04-29
Market cap
$1.16B
P/E ratio
408.88
P/S ratio
3.07x
EPS (TTM)
$0.04
Dividend yield
—
52W range
$9 – $21
Volume
0.0M
Pharming Group NV (PHAR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$16.36
12-Month target
$1.87
2030 Target
—
Intrinsic (DCF)
$18.77
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.2B | $0.2B | $0.3B | $0.4B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.76%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.